Biote Corp (BTMD)
6.14
+0.08
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
6.13
-0.01
(-0.16%)
After-Hours: 20:00
Biote Enterprise Value: 275.12M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 275.12M |
| November 20, 2024 | 272.63M |
| November 19, 2024 | 273.57M |
| November 18, 2024 | 275.75M |
| November 15, 2024 | 251.79M |
| November 14, 2024 | 288.50M |
| November 13, 2024 | 293.17M |
| November 12, 2024 | 255.83M |
| November 11, 2024 | 262.99M |
| November 08, 2024 | 257.08M |
| November 07, 2024 | 259.88M |
| November 06, 2024 | 258.01M |
| November 05, 2024 | 246.50M |
| November 04, 2024 | 244.94M |
| November 01, 2024 | 246.81M |
| October 31, 2024 | 242.77M |
| October 30, 2024 | 243.39M |
| October 29, 2024 | 246.81M |
| October 28, 2024 | 247.12M |
| October 25, 2024 | 243.70M |
| October 24, 2024 | 240.28M |
| October 23, 2024 | 245.88M |
| October 22, 2024 | 245.88M |
| October 21, 2024 | 244.94M |
| October 18, 2024 | 249.61M |
| Date | Value |
|---|---|
| October 17, 2024 | 249.61M |
| October 16, 2024 | 253.66M |
| October 15, 2024 | 250.86M |
| October 14, 2024 | 245.88M |
| October 11, 2024 | 247.74M |
| October 10, 2024 | 244.94M |
| October 09, 2024 | 247.74M |
| October 08, 2024 | 246.19M |
| October 07, 2024 | 243.70M |
| October 04, 2024 | 243.70M |
| October 03, 2024 | 239.65M |
| October 02, 2024 | 246.50M |
| October 01, 2024 | 254.59M |
| September 30, 2024 | 257.70M |
| September 27, 2024 | 271.17M |
| September 26, 2024 | 264.35M |
| September 25, 2024 | 265.28M |
| September 24, 2024 | 275.19M |
| September 23, 2024 | 281.70M |
| September 20, 2024 | 282.32M |
| September 19, 2024 | 284.80M |
| September 18, 2024 | 277.67M |
| September 17, 2024 | 282.01M |
| September 16, 2024 | 278.60M |
| September 13, 2024 | 277.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.78M
Minimum
Aug 22 2022
354.54M
Maximum
Jul 16 2024
142.67M
Average
152.84M
Median
Jan 30 2024
Enterprise Value Benchmarks
| American Shared Hospital Services | 34.29M |
| Omnicell Inc | 2.033B |
| Astrana Health Inc | 1.813B |
| Cryo-Cell International Inc | 75.52M |
| P3 Health Partners Inc | 248.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 10.70M |
| Revenue (Quarterly) | 51.38M |
| Total Expenses (Quarterly) | 39.20M |
| EPS Diluted (Quarterly) | 0.33 |
| Gross Profit Margin (Quarterly) | 70.47% |
| Profit Margin (Quarterly) | 20.83% |
| Earnings Yield | 4.23% |
| Operating Earnings Yield | 16.70% |
| Normalized Earnings Yield | 9.219 |